ExCulture has secured €350,000 from UNIIQ/Delft Enterprises. This substantial funding, combined with the support of UNIIQ will propel ExCulture further on our mission to develop an animal-free, alternative heparin. We are grateful to have the opportunity to contribute to the innovation ecosystem of Zuid Holland.
For more information check out the UNIIQ press release here.
Leiden, 12th July 2024 - ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation,...
On Friday 12th April 2024 ExCulture was announced as winner of the 2024 DSM-Firmenich Kickstart Prize, securing €50,000 after pitching to and...
Looking back on a successful first experience of the BioEurope Spring Conference held in Barcelona for ExCulture.We had the opportunity to make many...